SPY336.83-0.61 -0.18%
DIA279.42-0.62 -0.22%
IXIC11,042.50+30.27 0.27%

Marinus Pharmaceuticals Q3 EPS $(0.26) Up From $(0.27) YoY

Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly losses of $(0.26) per share. This is a 3.7 percent increase over losses of $(0.27) per share from the same period last year.

Benzinga · -

Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly losses of $(0.26) per share. This is a 3.7 percent increase over losses of $(0.27) per share from the same period last year.